STOCK TITAN

If You Invested in enGene Therapeutics Inc. Warrants (ENGNW)

Biological Products, (no Diagnostic Substances) · NASDAQ
Looking for the current price? See the ENGNW quote & overview
$1,000 invested 1 Year Ago
$153
-84.7% price return -85.0% CAGR
-84.7% with dividends reinvested
Bought on Nov 10, 2025 at $1.30 split-adjusted
$1,000 invested 5 Years Ago
N/A
Our prices start Nov 1, 2023
$1,000 invested 10 Years Ago
N/A
Our prices start Nov 1, 2023

What $1,000 or $10,000 in ENGNW Would Be Worth Now

Real historical value by amount invested and how long ago
If you invested 1 year ago 5 years ago 10 years ago Since Nov 1, 2023
$1,000 $153 -85% — — $199 -80%
$10,000 $1,533 -85% — — $1,993 -80%

Based on real historical closing prices adjusted for stock splits, without dividends, through 2026-11-06. Figures with dividends reinvest each cash dividend at the previous close less the dividend, before taxes. Past performance does not guarantee future results.

Custom Calculation

Choose your own date and amount for ENGNW

$1,000 Investment Over Time

ENGNW vs S&P 500

Year-by-Year Returns

ENGNW annual performance
Year Start Price End Price Annual Return Cumulative
2023Nov 1, 2023 to Dec 29, 2023 $1.00 $0.85 -15.0% -15.0%
2024 $0.85 $0.8433 -0.8% -15.7%
2025Dec 31, 2024 to Dec 30, 2025 $0.8433 $2.96 +251.0% +196.0%
2026Dec 30, 2025 to Nov 6, 2026 $2.96 $0.1993 -93.3% -80.1%

About enGene Therapeutics Inc. Warrants

NASDAQ

Current Price
$0.1993
EPS (FY2025)
$2.29
View full ENGNW overview

Frequently Asked Questions

enGene Therapeutics Inc. Warrants investment returns

How much would $1,000 invested in enGene Therapeutics Inc. Warrants be worth today?

If you invested $1,000 in enGene Therapeutics Inc. Warrants (ENGNW) 1 year ago on 2025-11-10, your investment would be worth $153 as of 2026-11-06, a -84.7% price return without dividends, growing at a compounded rate of -85.0% per year (CAGR).

Has enGene Therapeutics Inc. Warrants outperformed the S&P 500?

Comparison data requires at least 10 years of trading history. Use the calculator above to compare ENGNW performance over available time periods.

What is enGene Therapeutics Inc. Warrants's average annual return?

The compound annual growth rate (CAGR) of ENGNW’s share price over the past 1 year is -85.0%, without dividends. Individual years vary a great deal, and ENGNW’s best recent full year was 2024 (-0.8%) while the worst was 2024 (-0.8%).

For informational and educational purposes only, not investment advice.